Expects To Announce Data For Factor Viii Expression In Non-Human Primates In 2023
Feb 23 (Reuters) - Generation Bio Co GBIO.O :
* GENERATION BIO CO - EXPECTS TO ANNOUNCE DATA FOR FACTOR
VIII
EXPRESSION IN NON-HUMAN PRIMATES IN 2023
* GENERATION BIO CO QUARTERLY LOSS PER SHARE $0.55
* GENERATION BIO CO - CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES WERE $279.1 MILLION AS OF DECEMBER 31, 2022
* GENERATION BIO CO - CONTINUES TO BELIEVE THAT ITS CASH
POSITION
WILL FUND ITS OPERATING PLAN INTO 2025
Further company coverage: GBIO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Generation Bio
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Nodthera Appoints Geoff Mcdonough, M.D., As Independent Board Member